{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T13:09:37Z","timestamp":1695042577002},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00105-017-4079-0","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T10:09:41Z","timestamp":1509962981000},"page":"994-998","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acne inversa\/Hidradenitis suppurativa: Eine Herausforderung f\u00fcr die Zukunft"],"prefix":"10.1007","volume":"68","author":[{"given":"R.","family":"Sabat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"issue":"2","key":"4079_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB (2012) Clinical practice. Hidradenitis suppurativa. N\u00a0Engl J Med 366(2):158\u2013164","journal-title":"N Engl J Med"},{"issue":"6","key":"4079_CR2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM et\u00a0al (2015) Diagnostic delay in hidradenitis suppurativa is a\u00a0global problem. Br J Dermatol 173(6):1546\u20131549","journal-title":"Br J Dermatol"},{"issue":"4","key":"4079_CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein P et\u00a0al (2007) Quality of life impairment in hidradenitis suppurativa: a\u00a0study of 61 cases. J\u00a0Am Acad Dermatol 56(4):621\u2013623","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4079_CR4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC (2010) Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 90(3):264\u2013268","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"4079_CR5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","volume":"67","author":"A Kurek","year":"2012","unstructured":"Kurek A et\u00a0al (2012) Profound disturbances of sexual health in patients with acne inversa. J\u00a0Am Acad Dermatol 67(3):422\u2013428, 428.e1","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"4079_CR6","first-page":"743","volume":"11","author":"A Kurek","year":"2013","unstructured":"Kurek A et al (2013) Depression is a\u00a0frequent co-morbidity in patients with acne inversa. J\u00a0Dtsch Dermatol Ges 11(8):743\u2013749, 743\u2013750","journal-title":"J Dtsch Dermatol Ges"},{"key":"4079_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.008","author":"L Thorlacis","year":"2017","unstructured":"Thorlacis L et\u00a0al (2017) Increased suicide risk in patients with Hidradenitis Suppurativa. J\u00a0Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2017.09.008","journal-title":"J Invest Dermatol"},{"issue":"2","key":"4079_CR8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk K et al (2011) Deficiency of IL-22 contributes to a\u00a0chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J\u00a0Immunol 186(2):1228\u20131239","journal-title":"J Immunol"},{"issue":"1","key":"4079_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13(1):21\u201338","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"4079_CR10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC et\u00a0al (2017) The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol 153(9):897\u2013905","journal-title":"JAMA Dermatol"},{"issue":"4","key":"4079_CR11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","volume":"176","author":"HC Ring","year":"2017","unstructured":"Ring HC et\u00a0al (2017) Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol 176(4):993\u20131000","journal-title":"Br J Dermatol"},{"issue":"6","key":"4079_CR12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH Zee van der","year":"2011","unstructured":"van der Zee HH et al (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a\u00a0rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164(6):1292\u20131298","journal-title":"Br J Dermatol"},{"issue":"3","key":"4079_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","volume":"133","author":"AE Pink","year":"2013","unstructured":"Pink AE et al (2013) gamma-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J\u00a0Invest Dermatol 133(3):601\u2013607","journal-title":"J Invest Dermatol"},{"issue":"1","key":"4079_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjd.15076","volume":"176","author":"H Xu","year":"2017","unstructured":"Xu H et\u00a0al (2017) NCSTN mutations in hidradenitis suppurativa\/acne inversa do not influence cytokine production by peripheral blood mononuclear cells. Br J Dermatol 176(1):277\u2013279","journal-title":"Br J Dermatol"},{"key":"4079_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15748","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis CC et\u00a0al (2017) Development and validation of IHS4, a\u00a0novel dynamic scoring system to assess hidradenitis suppurativa\/acne inversa severity. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.15748","journal-title":"Br J Dermatol"},{"key":"4079_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15424","author":"K Wolk","year":"2017","unstructured":"Wolk K et al (2017) Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa\/hidradenitis suppurativa. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.15424","journal-title":"Br J Dermatol"},{"key":"4079_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4097574","author":"A Tsaousi","year":"2016","unstructured":"Tsaousi A et\u00a0al (2016) MMP8 is increased in lesions and blood of acne Inversa patients: a potential link to skin destruction and metabolic alterations. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2016\/4097574","journal-title":"Mediators Inflamm."},{"issue":"6","key":"4079_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2340\/00015555-2061","volume":"95","author":"L Matusiak","year":"2015","unstructured":"Matusiak L et al (2015) Chitinase-3-like protein 1 (YKL-40): novel biomarker of hidradenitis suppurativa disease activity? Acta Derm Venereol 95(6):736\u2013737","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"4079_CR19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/13547500903075218","volume":"14","author":"L Matusiak","year":"2009","unstructured":"Matusiak L, Bieniek A, Szepietowski JC (2009) Soluble interleukin-2 receptor serum level is a\u00a0useful marker of hidradenitis suppurativa clinical staging. Biomarkers 14(6):432\u2013437","journal-title":"Biomarkers"},{"issue":"5","key":"4079_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB et\u00a0al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N\u00a0Engl J Med 375(5):422\u2013434","journal-title":"N Engl J Med"},{"issue":"6","key":"4079_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00105-016-3812-4","volume":"67","author":"S Philipp","year":"2016","unstructured":"Philipp S, Kokolakis G, Sabat R (2016) Systemic treatments for psoriasis and psoriatic arthritis. Hautarzt 67(6):464\u2013471","journal-title":"Hautarzt"},{"issue":"2","key":"4079_CR22","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","volume":"7","author":"R Sabat","year":"2012","unstructured":"Sabat R et\u00a0al (2012) Increased prevalence of metabolic syndrome in patients with acne inversa. PLOS ONE 7(2):e31810","journal-title":"PLOS ONE"},{"issue":"4","key":"4079_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","volume":"152","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Gislason GH, Hansen PR (2016) Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa. JAMA Dermatol 152(4):429\u2013434","journal-title":"JAMA Dermatol"},{"key":"4079_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13578-015-0060-8","volume":"5","author":"R Sabat","year":"2015","unstructured":"Sabat R, Wolk K (2015) Deciphering the role of interleukin-22 in metabolic alterations. Cell Biosci 5:68","journal-title":"Cell Biosci"},{"issue":"5","key":"4079_CR25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000448838","volume":"232","author":"S Schneider-Burrus","year":"2016","unstructured":"Schneider-Burrus S et al (2016) High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa. Dermatology 232(5):606\u2013612","journal-title":"Dermatology"},{"issue":"1","key":"4079_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","volume":"76","author":"IE Deckers","year":"2017","unstructured":"Deckers IE et al (2017) Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a\u00a0multicenter cross-sectional study. J\u00a0Am Acad Dermatol 76(1):49\u201353","journal-title":"J Am Acad Dermatol"},{"key":"4079_CR27","doi-asserted-by":"crossref","unstructured":"Jemec GBE, Kimball AB, (2015) Hidradenitis suppurativa: Epidemiology and scope of the problem. J\u00a0Am Acad Dermatol 73(5):S4\u2013S7","DOI":"10.1016\/j.jaad.2015.07.052"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4079-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T17:23:51Z","timestamp":1570296231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4079-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4079"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4079-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]}}}